{
    "2018-02-06": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Bristol-Myers' Opdivo/Yervoy Combo Positive in Cancer Study",
                "features": {
                    "keywords": [
                        "Opdivo",
                        "Yervoy",
                        "Combo",
                        "Positive",
                        "Cancer",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "FOCUS-In diabetes war, Novo Nordisk aims to break mould with new pill",
                "features": {
                    "keywords": [
                        "diabetes",
                        "Novo Nordisk",
                        "new pill"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-06",
                "original_text": "Free Post Earnings Research Report: AbbVieâ€™s Q4 FY17 Results Beat Market Estimates",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Q4",
                        "FY17",
                        "Results",
                        "Beat",
                        "Market Estimates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}